352 related articles for article (PubMed ID: 19124345)
1. Rho kinase as a therapeutic target in the treatment of asthma and chronic obstructive pulmonary disease.
Fernandes LB; Henry PJ; Goldie RG
Ther Adv Respir Dis; 2007 Oct; 1(1):25-33. PubMed ID: 19124345
[TBL] [Abstract][Full Text] [Related]
2. Rho-kinase and contractile apparatus proteins in murine airway hyperresponsiveness.
Witzenrath M; Ahrens B; Schmeck B; Kube SM; Hippenstiel S; Rosseau S; Hamelmann E; Suttorp N; Schütte H
Exp Toxicol Pathol; 2008 Jun; 60(1):9-15. PubMed ID: 18434112
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of Rho-kinase inhibitors in asthma.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Med Hypotheses; 2007; 68(3):705-6. PubMed ID: 17055188
[No Abstract] [Full Text] [Related]
4. Small molecule inhibitors of cell signaling: novel future therapeutics for asthma and chronic obstructive pulmonary diseases.
Blease K; Raymon HK
Curr Opin Investig Drugs; 2003 May; 4(5):544-51. PubMed ID: 12833647
[TBL] [Abstract][Full Text] [Related]
5. An assessment of therapeutic regimens in the treatment of acute exacerbations in chronic obstructive pulmonary disease and asthma.
Skrepnek GH; Skrepnek SV
Am J Manag Care; 2004 Jul; 10(5 Suppl):S139-52. PubMed ID: 15354679
[TBL] [Abstract][Full Text] [Related]
6. Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease.
Redington AE
Eur J Pharmacol; 2006 Mar; 533(1-3):263-76. PubMed ID: 16466650
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease.
McNamara PS; Smyth RL
Drug News Perspect; 2005 Dec; 18(10):615-21. PubMed ID: 16491163
[TBL] [Abstract][Full Text] [Related]
8. Airway nitrergic pathways: is there therapeutic potential in asthma and COPD?
Folkerts G; Nijkamp FP
Curr Opin Pharmacol; 2004 Jun; 4(3):202-6. PubMed ID: 15140409
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
Cataldo DD; Gueders MM; Rocks N; Sounni NE; Evrard B; Bartsch P; Louis R; Noel A; Foidart JM
Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):875-84. PubMed ID: 14656045
[TBL] [Abstract][Full Text] [Related]
10. Chronic obstructive pulmonary disease in a new concept.
Murărescu ED; Mitrofan EC; Mihailovici MS
Rom J Morphol Embryol; 2007; 48(3):207-14. PubMed ID: 17914487
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA
J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934
[TBL] [Abstract][Full Text] [Related]
12. Defective apoptotic cell clearance in asthma and COPD--a new drug target for statins?
Walsh GM
Trends Pharmacol Sci; 2008 Jan; 29(1):6-11. PubMed ID: 18054798
[TBL] [Abstract][Full Text] [Related]
13. Immunology of asthma and chronic obstructive pulmonary disease.
Barnes PJ
Nat Rev Immunol; 2008 Mar; 8(3):183-92. PubMed ID: 18274560
[TBL] [Abstract][Full Text] [Related]
14. The potential therapeutic role of potassium channel modulators in asthma and chronic obstructive pulmonary disease.
Malerba M; Radaeli A; Mancuso S; Polosa R
J Biol Regul Homeost Agents; 2010; 24(2):123-30. PubMed ID: 20487625
[TBL] [Abstract][Full Text] [Related]
15. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?
Beeh KM; Beier J
Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851
[TBL] [Abstract][Full Text] [Related]
16. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
Onoue S; Misaka S; Kawabata Y; Yamada S
Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment in asthma and COPD.
Hoshino T; Toda R; Aizawa H
Allergol Int; 2009 Sep; 58(3):341-6. PubMed ID: 19628978
[TBL] [Abstract][Full Text] [Related]
18. Rho signaling inhibitor, Y-27632, inhibits invasiveness of metastastic hepatocellular carcinoma in a mouse model.
Xue F; Zhang JJ; Qiu F; Zhang M; Chen XS; Li QG; Han LZ; Xi ZF; Xia Q
Chin Med J (Engl); 2007 Dec; 120(24):2304-7. PubMed ID: 18167222
[No Abstract] [Full Text] [Related]
19. Estrogen as a new therapeutic target for asthma and chronic obstructive pulmonary disease.
Dimitropoulou C; Drakopanagiotakis F; Catravas JD
Drug News Perspect; 2007 May; 20(4):241-52. PubMed ID: 17637937
[TBL] [Abstract][Full Text] [Related]
20. Targeting selectins for the treatment of respiratory diseases.
Romano SJ; Slee DH
Curr Opin Investig Drugs; 2001 Jul; 2(7):907-13. PubMed ID: 11757789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
